1-(3-(dimethylamino)propyl)-3-(4-(furan-3-yl)thieno[2,3-d]pyrimidin-2-yl)guanidine

ID: ALA5220780

PubChem CID: 168299483

Max Phase: Preclinical

Molecular Formula: C16H20N6OS

Molecular Weight: 344.44

Names and Identifiers

Canonical SMILES:  CN(C)CCCNC(=N)Nc1nc(-c2ccoc2)c2ccsc2n1

Standard InChI:  InChI=1S/C16H20N6OS/c1-22(2)7-3-6-18-15(17)21-16-19-13(11-4-8-23-10-11)12-5-9-24-14(12)20-16/h4-5,8-10H,3,6-7H2,1-2H3,(H3,17,18,19,20,21)

Standard InChI Key:  OZUQFYNLRQCGDD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -4.1910   -1.7661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6036   -1.0517    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0515   -0.4387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2979   -0.7742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3841   -1.5946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5831   -0.3615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5831    0.4638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8703    0.8747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1552    0.4621    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1534   -0.3590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8652   -0.7756    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4386   -0.7715    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2761   -0.3590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2761    0.4663    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9909   -0.7715    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7056   -0.3590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4204   -0.7715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1352   -0.3590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8500   -0.7715    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6036   -0.4360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9362   -1.5921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0408    1.6796    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1942    1.0147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8590    1.7661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  5  4  1  0
  5  1  2  0
  6  4  1  0
  6  7  2  0
  7  8  1  0
  9  8  2  0
 10  9  1  0
 11 10  2  0
  6 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 20 19  1  0
 21 19  1  0
  8 22  1  0
  7 23  1  0
 23 24  2  0
 24 22  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA5220780

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 344.44

Molecular Weight (Monoisotopic): 344.1419

AlogP: 2.84

#Rotatable Bonds: 6

Polar Surface Area: 90.07

Molecular Species: BASE

HBA: 6

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 8.81

CX LogP: 2.48

CX LogD: 0.81

Aromatic Rings: 3

Heavy Atoms: 24

QED Weighted: 0.36

Np Likeness Score: -1.22

References

1. Morrill C, Friesen WJ, Babu S, Baiazitov RY, Du W, Karloff DB, Lee CS, Moon YC, Ren H, Sierra J, Tomizawa Y, Vazirani P, Welch EM, Xue X, Zhuo J..  (2022)  Guanidino quinazolines and pyrimidines promote readthrough of premature termination codons in cells with native nonsense mutations.,  76  [PMID:36150638] [10.1016/j.bmcl.2022.128989]

Source

Source(1):

• Scientific Literature